A vi­ral vec­tor play­er is ex­pand­ing its foot­print in Basque Coun­try amid height­ened de­mand

As the de­mand for vi­ral vec­tors grows un­abat­ed amid the Covid-19 pan­dem­ic, a CD­MO is drop­ping a se­ri­ous in­vest­ment to build out a new Basque Coun­try fa­cil­i­ty.

The new fa­cil­i­ty is in the same tech­nol­o­gy park as Vi­ral­gen’s ex­ist­ing man­u­fac­tur­ing site. It in­creas­es ca­pac­i­ty five-fold, and clients should ex­pect the first batch­es from its 2,000-liter biore­ac­tor re­leased by the mid­dle of next year. The $83.1 mil­lion in­vest­ment will turn in­to a $142.4 mil­lion tab af­ter the fi­nal two build­ings are com­plet­ed. The ex­pan­sion will bring 130 new jobs to Vi­ral­gen, which should grow the team to 250 peo­ple by 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER